Categories Earnings, Health Care
Earnings Summary: Becton, Dickinson, and Company reports Q4 2023 results
Medical technology company Becton, Dickinson, and Company (NYSE: BDX) announced results for the final three months of fiscal 2023.
- Fourth-quarter revenue increased 6.8% to $5.1 billion as reported and rose 5.9% on a currency-neutral basis
- Revenue from the base business, which excludes COVID-only diagnostic testing, grew 7.3% as reported and 6.3% currency-neutral
- Earnings from continuing operations were $0.53 per share in Q4, vs. $0.93 per share last year
- Earnings from continuing operations, on an adjusted basis, came in at $3.42 per share, up 24.4% year-over-year
- The company expects fiscal year 2024 revenues to be in the range of $20.1 billion to $20.3 billion
- Full-year adjusted profit is expected to be between $12.70 per share and $13.00 per share
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
